{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:01:50Z","timestamp":1783191710737,"version":"3.54.6"},"reference-count":33,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Joint TCM Science&Technology Project of National Demonstration Zones for Comprehensive TCM Reform","award":["No.GZY-KJS-ZJ-2025-013"],"award-info":[{"award-number":["No.GZY-KJS-ZJ-2025-013"]}]},{"name":"Natural Science Foundation of Hangzhou","award":["No.2024SZRYBH280002"],"award-info":[{"award-number":["No.2024SZRYBH280002"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Drug Safety"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Muscle relaxants are widely used for the treatment of ankylosing spondylitis (AS) and inevitably have many adverse reactions. Individuals with AS frequently present with ocular symptoms. However, the association of muscle relaxants with the increase of dry eye or Sjogren\u2019s syndrome (SS) in AS patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To investigate the association between muscle relaxant use and the risks of Sj\u00f6gren\u2019s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with AS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A population-based retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This population-based retrospective cohort study identified patients suffering from AS between 2007 and 2017 (\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      \u2009=\u200926,806,963) in the National Health Insurance Research Database (NHIRD) of Taiwan. The demographic data of two study groups, namely muscle relaxant users and non-users, were collected in the present study. The inverse probability of treatment weighting (IPTW) was used to balance the clinical confounders. Furthermore, we used Kaplan\u2013Meier analyses and Cox proportional hazard regression to analyze the association between cumulative muscle relaxant use and SS or dry eye risk in AS patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      After exclusion, 68,970 muscle relaxant users and 31,863 non-users were included in our study. The risks of composite outcome (hazard ratios (HR) 1.37 (1.31\u20131.43), aHR1.18 (1.13\u20131.24), and IPTW HR 1.17 (1.13\u20131.22)), Sjogren\u2019s syndrome (HR 1.63 (1.47\u20131.79), aHR 1.44 (1.30\u20131.59), and IPTW HR 1.45 (1.32\u20131.59)), Dry eye disease (including keratoconjunctivitis sicca) (HR 1.32 (1.26\u20131.39), aHR 1.12 (1.06\u20131.17), and IPTW HR 1.11 (1.06\u20131.16)) were all significantly higher among muscle relaxant users (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Moreover, higher doses of muscle relaxant use increased higher risks of composite outcome (25&lt; medication possession ratio (MPR), aHR\u2009=\u20091.77 (1.60\u20131.96)) and dry eye disease (25&lt; MPR, aHR\u2009=\u20091.74 (1.56\u20131.94)) (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.0001 for trend). However, there was higher risk of Sjogren\u2019s syndrome among the patients who received 5&lt; MPR \u2a7d10 (aHR\u2009=\u20091.70 (1.49\u20131.93)). Muscle relaxant users who received ethers chemically related to antihistamines and oral muscle relaxant users had higher risks of composite outcome, Sjogren\u2019s syndrome, and dry eye disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study demonstrates that cumulative muscle relaxant exposure might increase the risk of dry eye or even SS at a dose-dependent manner.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20420986261460145","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:26:05Z","timestamp":1782206765000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Muscle relaxant use and the associated risk of Sj\u00f6gren\u2019s syndrome and dry eye disease (including keratoconjunctivitis sicca) in patients with ankylosing spondylitis: a population-based cohort study"],"prefix":"10.1177","volume":"17","author":[{"given":"Weijie","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, No.318, Chaowang Road, Hangzhou, Zhejiang Province 310005, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3662-9961","authenticated-orcid":false,"given":"Shujun","family":"Xia","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Allergy, Immunology &amp; Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Allergy, Immunology &amp; Rheumatology, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Road, South District, Taichung City 40201, Taiwan"},{"name":"Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan"},{"name":"Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.04.005"},{"issue":"4","key":"e_1_3_4_3_2","first-page":"301","article-title":"Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sj\u00f6gren\u2019s syndrome","volume":"126","author":"Vehof J","year":"2020","unstructured":"Vehof J, Utheim TP, Bootsma H, et al. Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 2020; 38 Suppl. 126(4): 301\u2013309.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(02)00414-1"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0255-9"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.41042"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.brs.0000146453.76528.7c"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199244040-00006"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856020-00006"},{"issue":"2","key":"e_1_3_4_12_2","article-title":"Muscle relaxants for non-specific low back pain","volume":"2003","author":"van Tulder MW","year":"2003","unstructured":"van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003; 2003(2): Cd004252.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/20420986211014639"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92146-4"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001865"},{"issue":"6","key":"e_1_3_4_16_2","first-page":"677","article-title":"Efficacy and safety of the combination of diclofenac and thiocolchicoside in the treatment of low back pain and other conditions: systematic review of the literature","volume":"13","author":"Oikonomou I","year":"2025","unstructured":"Oikonomou I, Akinosoglou K. Efficacy and safety of the combination of diclofenac and thiocolchicoside in the treatment of low back pain and other conditions: systematic review of the literature. Healthcare (Basel, Switzerland) 2025; 13(6): 677.","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206133"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0573-6"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003596"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2014.05.049"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19580-y"},{"issue":"2","key":"e_1_3_4_23_2","first-page":"302","article-title":"Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences","volume":"21","author":"Chou CT","year":"1994","unstructured":"Chou CT, Pei L, Chang DM, et al. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994; 21(2): 302\u2013306.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305201"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318801673"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-0717-8_157"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7664"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.009"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110542"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22010134"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030347"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7546047"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3821-4"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2019.07.001"}],"container-title":["Therapeutic Advances in Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986261460145","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420986261460145","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986261460145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:47:09Z","timestamp":1782445629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420986261460145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["10.1177\/20420986261460145"],"URL":"https:\/\/doi.org\/10.1177\/20420986261460145","relation":{},"ISSN":["2042-0986","2042-0994"],"issn-type":[{"value":"2042-0986","type":"print"},{"value":"2042-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"20420986261460145"}}